Fiera Capital’s Biogen BIIB Stock Holding History

Fiera Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$2.07M	Buy	8,600 +2,525	+42%	+$565K	0.14%	59
2013 Q2	$1.31M	Buy	+6,075	New	+$1.3M	0.09%	75

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fiera Capital's BIIB Position: Q3 2013 in Review

Fiera Capital increased its Biogen (BIIB) stake by 42% in Q3 2013, buying an estimated $565K and bringing the position to 8,600 shares worth $2.07M. The position accounts for 0.14% of the portfolio, ranked #59.

Fiera Capital first reported a position in BIIB in Q2 2013 and has held it in 2 quarters since. 656 funds tracked by Wall St. Rank hold BIIB as of Q3 2013.

Fiera Capital held 8,600 shares of Biogen worth $2.07M as of Q3 2013.
Fiera Capital bought 2,525 Biogen shares in Q3 2013, an estimated $565K.
Biogen made up 0.14% of Fiera Capital's portfolio in Q3 2013, its #59 holding.
Fiera Capital first reported a position in Biogen in Q2 2013 and has held it in 2 quarters since.
656 funds tracked by Wall St. Rank held Biogen as of Q3 2013.

Based on Fiera Capital's 13F filing for Q3 2013, filed 14 Nov 2013.